Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lidocaine 20mg/2ml (1%) solution for injection ampoules
1502010J0AABUBU
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 68,466 |
|
Emla 5% cream
1502010J0BEAABY
|
Emla | Lidocaine hydrochloride | Anaesthesia | 61,905 |
|
Lidocaine 700mg medicated plasters
1502010J0AAELEL
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 33,568 |
|
Instillagel gel
1502010J0BDAABQ
|
Instillagel | Lidocaine hydrochloride | Anaesthesia | 29,019 |
|
Lidocaine 40mg/2ml (2%) solution for injection ampoules
1502010J0AABEBE
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 28,268 |
|
Lidocaine 50mg/5ml (1%) solution for injection ampoules
1502010J0AABDBD
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 24,917 |
|
Ralvo 700mg medicated plasters
1502010J0BWAAEL
|
Ralvo (Lidocaine hydrochloride) | Lidocaine hydrochloride | Anaesthesia | 19,143 |
|
Lidocaine 2.5% / Prilocaine 2.5% cream
1502010J0AABYBY
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 11,005 |
|
Lidocaine 100mg/5ml (2%) solution for injection ampoules
1502010J0AACBCB
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 9,091 |
|
Lignospan Special 20mg/ml / 12.5micrograms/ml inj 2.2ml cart
1502010J0BTAACQ
|
Lignospan Special | Lidocaine hydrochloride | Anaesthesia | 8,234 |
|
Xylocaine 1% with Adrenaline 100microg/20ml inj vials
1502010J0BBAXAY
|
Xylocaine (Gel/Injection/Solution) | Lidocaine hydrochloride | Anaesthesia | 7,414 |
|
Lidocaine 100mg/10ml (1%) solution for injection ampoules
1502010J0AABWBW
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 7,387 |
|
Versatis 700mg medicated plasters
1502010J0BSAAEL
|
Versatis (Lidocaine hydrochloride) | Lidocaine hydrochloride | Anaesthesia | 4,571 |
|
Lidocaine 2% and Chlorhexidine gel
1502010J0AABQBQ
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 3,251 |
|
Xylocaine 2% with Adrenaline 100microg/20ml inj vials
1502010J0BBA1A3
|
Xylocaine (Gel/Injection/Solution) | Lidocaine hydrochloride | Anaesthesia | 2,888 |
|
Lignospan Special 20mg/ml / 12.5micrograms/ml inj 1.8ml cart
1502010J0BTABEN
|
Lignospan Special | Lidocaine hydrochloride | Anaesthesia | 2,728 |
|
Lidocaine 200mg/Adrenaline (base) 100microg/20ml inj vials
1502010J0AAAYAY
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 2,700 |
|
Lidocaine 400mg/Adrenaline (base) 100microg/20ml inj vials
1502010J0AAA3A3
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 1,885 |
|
Bonjela Junior gel
1502010J0BVAAEQ
|
Bonjela | Lidocaine hydrochloride | Anaesthesia | 1,869 |
|
Nulbia 5% cream
1502010J0BXAABY
|
Nulbia | Lidocaine hydrochloride | Anaesthesia | 1,460 |
|
Germoloids cream
0107010N0BFAAAJ
|
Germoloids | Lidocaine hydrochloride | Gastro-Intestinal System | 1,457 |
|
Lidocaine 44mg/Adrenaline (base) 27.5microg/2.2ml inj cart
1502010J0AACQCQ
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 1,301 |
|
Germoloids ointment
0107010N0BFABAH
|
Germoloids | Lidocaine hydrochloride | Gastro-Intestinal System | 1,147 |
|
Germoloids suppositories
0107010N0BFACAG
|
Germoloids | Lidocaine hydrochloride | Gastro-Intestinal System | 996 |
|
Lidocaine 200mg/20ml (1%) solution for injection ampoules
1502010J0AACJCJ
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | 718 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.